BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MAF, MGC71685, 4094, ENSG00000178573 AND Prognosis
8 results:

  • 1. The mesocolic apical fragment in complete mesocolic excision colectomies: Should it be analysed separately? A proof-of-concept study.
    Livadaru C; Morarasu S; Bargaoanu R; Iacob S; Frunza T; Musina AM; Velenciuc N; Roata CE; Zugun-Eloae F; Ferariu D; Lunca S; Dimofte MG
    Colorectal Dis; 2023 Feb; 25(2):234-242. PubMed ID: 36227063
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Desmoplastic Reaction, Immune Cell Response, and prognosis in colorectal cancer.
    Akimoto N; Väyrynen JP; Zhao M; Ugai T; Fujiyoshi K; Borowsky J; Zhong R; Haruki K; Arima K; Lau MC; Kishikawa J; Twombly TS; Takashima Y; Song M; Zhang X; Wu K; Chan AT; Meyerhardt JA; Giannakis M; Nowak JA; Ogino S
    Front Immunol; 2022; 13():840198. PubMed ID: 35392092
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Training with Small Medical Data: Robust Bayesian Neural Networks for Colon cancer Overall Survival Prediction.
    Hsu TC; Lin C
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():2030-2033. PubMed ID: 34891686
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies.
    Tie J; Cohen JD; Lo SN; Wang Y; Li L; Christie M; Lee M; Wong R; Kosmider S; Skinner I; Wong HL; Lee B; Burge ME; Yip D; Karapetis CS; Price TJ; Tebbutt NC; Haydon AM; Ptak J; Schaeffer MJ; Silliman N; Dobbyn L; Popoli M; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
    Int J Cancer; 2021 Feb; 148(4):1014-1026. PubMed ID: 32984952
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A Prognostic Model Based on Six Metabolism-Related Genes in colorectal cancer.
    Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
    Biomed Res Int; 2020; 2020():5974350. PubMed ID: 32953885
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS-mutant metastatic colorectal cancer.
    Elez E; Chianese C; Sanz-García E; Martinelli E; Noguerido A; Mancuso FM; Caratù G; Matito J; Grasselli J; Cardone C; Esposito Abate R; Martini G; Santos C; Macarulla T; Argilés G; Capdevila J; Garcia A; Mulet N; Maiello E; Normanno N; Jones F; Tabernero J; Ciardello F; Salazar R; Vivancos A
    Mol Oncol; 2019 Sep; 13(9):1827-1835. PubMed ID: 31322322
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.
    Wang Y; Liu H; Hou Y; Zhou X; Liang L; Zhang Z; Shi H; Xu S; Hu P; Zheng Z; Liu R; Tang T; Ye F; Liang Z; Bu H
    Virchows Arch; 2018 Jun; 472(6):959-968. PubMed ID: 29705968
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Mucinous adenocarcinoma associated with a chronic perianal fistula - a review of cases from a single institution.
    Koyama F; Nakagawa T; Nakamura S; Ueda T; Nishigori N; Inoue T; Kawasaki K; Obara S; Nakamoto T; Uchimoto K; Fujii H; Kido A; Tanaka Y; Yoshida K; Fujimoto K; Kuwahara M; Nakajima Y
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1866-8. PubMed ID: 25731357
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.